| Platelet Disorders and Treatments | Lifetime | 70 | US 31 | 99.20 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 18 | US 9 | 99.29 |
| Cell Adhesion Molecules Research | Lifetime | 156 | US 87 | 99.36 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 182 | US 74 | 99.43 |
| Angiogenesis and VEGF in Cancer | Lifetime | 94 | US 47 | 99.27 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 169 | US 73 | 99.11 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 510 | US 243 | 98.60 |
| Cardiac tumors and thrombi | Lifetime | 149 | US 71 | 98.41 |
| Nanoparticle-Based Drug Delivery | Lifetime | 400 | US 84 | 98.36 |
| Thyroid Disorders and Treatments | Lifetime | 318 | US 125 | 97.68 |
| Nigella sativa pharmacological applications | Lifetime | 31 | US 2 | 96.33 |
| Protease and Inhibitor Mechanisms | Lifetime | 416 | US 180 | 97.40 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 416 | US 147 | 97.41 |
| Nanoplatforms for cancer theranostics | Lifetime | 819 | US 114 | 97.40 |
| Inflammatory mediators and NSAID effects | Lifetime | 763 | US 334 | 96.10 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 307 | US 153 | 93.96 |
| S100 Proteins and Annexins | Lifetime | 574 | US 262 | 94.98 |
| Retinoids in leukemia and cellular processes | Lifetime | 787 | US 383 | 94.50 |
| Blood disorders and treatments | Lifetime | 874 | US 340 | 92.02 |
| Tea Polyphenols and Effects | Lifetime | 673 | US 99 | 91.91 |
| Curcumin's Biomedical Applications | Lifetime | 593 | US 91 | 88.09 |
| Pomegranate: compositions and health benefits | Lifetime | 289 | US 39 | 86.41 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 577 | US 137 | 84.65 |
| Date Palm Research Studies | Lifetime | 861 | US 94 | 75.39 |
| Tannin, Tannase and Anticancer Activities | Lifetime | 555 | US 85 | 71.87 |
| Nigella sativa pharmacological applications | 2021-2025 | 15 | US 1 | 89.95 |
| Bioactive Compounds and Antitumor Agents | 2021-2025 | 140 | US 4 | 87.00 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 98 | US 7 | 81.58 |
| Estrogen and related hormone effects | 2021-2025 | 730 | US 227 | 74.67 |
| Cell Adhesion Molecules Research | 2021-2025 | 783 | US 204 | 71.25 |
| Thyroid Disorders and Treatments | 2021-2025 | 728 | US 85 | 74.22 |
| Pomegranate: compositions and health benefits | 2021-2025 | 179 | US 9 | 71.38 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 396 | US 127 | 68.94 |
